West Wealth Group
TARS icon

West Wealth Group’s Tarsus Pharmaceuticals TARS Stock Holding History

West Wealth Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$267K Hold
3,400
– – 0.04% 126
2026
Q2 		$214K Hold
3,400
– – 0.04% 134
2026
Q1 		$239K Hold
3,400
– – 0.05% 117
2025
Q4 		$278K Hold
3,400
– – 0.06% 100
2025
Q3 		$255K Buy
+3,400
New +$167K 0.06% 106

Other funds holding TARS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

West Wealth Group's TARS Position: Q3 2026 in Review

West Wealth Group held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 3,400 shares worth $267K. The position accounts for 0.04% of the portfolio, ranked #126.

West Wealth Group first reported a position in TARS in Q3 2025 and has held it in 5 quarters since. The position peaked at $278K in Q4 2025. 18 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • West Wealth Group held 3,400 shares of Tarsus Pharmaceuticals worth $267K as of Q3 2026.
  • West Wealth Group left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
  • Tarsus Pharmaceuticals made up 0.04% of West Wealth Group's portfolio in Q3 2026, its #126 holding.
  • West Wealth Group first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • West Wealth Group's Tarsus Pharmaceuticals position peaked at $278K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on West Wealth Group's 13F filing for Q3 2026, filed 14 Oct 2026.